AbbVie/Genmab’s lymphoma drug shows promise in phase 3 combination trial
Follicular lymphoma affects around 15,000 people in the US every year
Read More
Section: Regulatory
FDA approves Jazz Pharmaceuticals’ Modeyso as first drug for ultra-rare brain cancer
H3 K27M-mutant diffuse midline glioma affects an estimated 2,000 people in the US every year
Read More
Sanofi’s multiple myeloma candidate granted FDA orphan drug designation
More than 180,000 people worldwide are diagnosed with the disease every year
Read More
Johnson & Johnson files FDA application for Tremfya in psoriatic arthritis
Approximately 125 million people globally are living with some form of psoriasis
Read More
Gilead Sciences’ Biktarvy granted FDA approval for expanded HIV use
An estimated 1.2 million people in the US are currently living with the virus
Read More